65th American Society of Hematology Annual Meeting and Exposition
Poster Presentations
Abstract #: 2888
Title: Olutasidenib for the Treatment of mIDH1 Acute Myeloid Leukemia in Patients Relapsed or Refractory to Hematopoietic Stem Cell Transplant, Prior mIDH1 Inhibitor, or Venetoclax
Presenter: Jorge E. Cortes, M.D., Director, Georgia Cancer Center, Cecil F. Whitaker Jr., GRA Eminent Scholar Chair in Cancer, and Phase 2 Trial Investigator
Session Name: 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II
Date: Sunday, December 10, 2023
Presentation Time: 6:00-8:00 PM PT
Location: San Diego Convention Center, Halls G-H
Abstract #: 1872
Title: Olutasidenib Alone or in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Myelodysplastic Syndromes/Neoplasms (MDS)
Presenter: Jorge E. Cortes, M.D., Director, Georgia Cancer Center, Cecil F. Whitaker Jr., GRA Eminent Scholar Chair in Cancer, and Phase 2 Trial Investigator
Session Name: 637. Myelodysplastic Syndromes – Clinical and Epidemiological: Poster I
Date: Saturday, December 9, 2023
Presentation Time: 5:30-7:30 PM PT
Location: San Diego Convention Center, Halls G-H
Abstract #: 3247
Title: Phase 1b Trial of IRAK 1/4 Inhibition for Low-Risk Myelodysplastic Syndrome Refractory/Resistant to Prior Therapies: A Trial In Progress
Presenter: Guillermo Garcia-Manero, M.D., The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
Session Name: 637. Myelodysplastic Syndromes – Clinical and Epidemiological: Poster II
Date: Sunday, December 10, 2023
Presentation Time: 6:00-8:00 PM PT
Location: San Diego Convention Center, Halls G-H
Abstract #: 2578 Title: Long-Term Treatment with Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia: An Open-Label Extension Study Following a Phase 3 Placebo-Controlled, Double-Blind, Parallel-Group Study Session Name: 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II Date: Sunday, December 10, 2023 Presentation Time: 6:00-8:00 PM PT Location: San Diego Convention Center, Halls G-H
The conference abstracts can be accessed here.